SYNH stock forecast
Our latest prediction for Syneos Health, Inc.'s stock price was made on the Dec. 17, 2018 when the stock price was at 41.29$.
In the short term (2weeks), SYNH's stock price should outperform the market by 1.77%. During that period the price should oscillate between -5.37% and +7.88%.
In the medium term (3months), SYNH's stock price should outperform the market by 1.17%. During that period the price should oscillate between -10.62% and +18.75%.Get email alerts
About Syneos Health, Inc.
Syneos Health, Inc. provides outsourced clinical development and commercialization services to biopharmaceutical companies. It operates through the following business segments: Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers clinical development services spanning Phase I to Phase IV, including global studies, as well as unbundled service offerings such as clinical monitoring, investigator recruitment, patient recruitment, data management, and study startup to assist customers with their drug development process. The Commercial Solutions segment provides commercialization services, including outsourced field selling solutions, medication adherence, communications, and consulting services. The company was founded on August 13, 2010 and is headquartered in Morrisville, NC.
At the moment the company generates 4321M USD in revenues.
On its last earning announcement, the company reported a loss of -0.16$ per share.
The book value per share is 27.43$
Three months stock forecastDec. 17, 2018
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|